Ask Warren

Theragen Etex

066700 · KOSDAQ · ₩066700 · 테라젠이텍스

₩1,980▲ ₩5 (0.25%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩69B₩69B₩69B₩69B₩67B₩67B₩66B₩60B
Cost of sales₩33B₩33B₩34B₩32B₩32B₩32B₩33B₩30B
Gross profit₩37B₩35B₩35B₩37B₩34B₩35B₩33B₩30B
Operating income₩2.6B₩1.9B₩4.2B₩2B−₩476M₩4.5B₩2.4B₩2.8B
Net income−₩3.8B−₩3.4B₩8B₩3B₩3.3B−₩2.5B−₩43B₩2.2B
Net income to shareholders−₩3.4B−₩3.7B₩6.8B₩3B₩3.3B−₩2.5B−₩45B₩2.2B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩241B₩253B₩258B₩245B₩237B₩244B₩237B₩297B
Current assets₩161B₩172B₩174B₩163B₩148B₩158B₩151B₩127B
Cash and equivalents₩40B₩38B₩35B₩33B₩28B₩39B₩22B₩27B
Total liabilities₩97B₩101B₩98B₩100B₩96B₩103B₩106B₩112B
Current liabilities₩91B₩92B₩89B₩93B₩89B₩96B₩100B₩101B
Borrowings₩40B₩41B₩41B₩42B₩43B₩49B₩49B₩50B
Total equity₩144B₩152B₩159B₩145B₩142B₩141B₩131B₩185B
Shareholders' equity₩124B₩132B₩139B₩125B₩123B₩122B₩112B₩166B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩3.7B₩3.1B₩3.8B₩3.3B₩520M₩3.3B−₩1.2B₩585M
Capital spending₩1.6B₩623M₩668M₩661M₩767M₩481M₩2.3B₩5.1B
Free cash flow₩2.1B₩2.5B₩3.1B₩2.7B−₩246M₩2.8B−₩3.5B−₩4.5B
Dividends paid——₩99M−₩99M——₩0₩0

Consolidated where available. Amounts in won.

Also known as: Theragen Etex / 테라젠이텍스 / 066700 / KRX:066700

Source: KRX statistical information